APA

Boyd K. D., Ross F. M., Chiecchio L., Dagrada G. P., Konn Z. J., Tapper W. J., Walker B. A., Wardell C. P., Gregory W. M., Szubert A. J., Bell S. E., Child J. A., Jackson G. H., Davies F. E. & Morgan G. J. (20120330). A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial. : Leukemia.

Chicago

Boyd K D, Ross F M, Chiecchio L, Dagrada G P, Konn Z J, Tapper W J, Walker B A, Wardell C P, Gregory W M, Szubert A J, Bell S E, Child J A, Jackson G H, Davies F E and Morgan G J. 20120330. A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial. : Leukemia.

Harvard

Boyd K. D., Ross F. M., Chiecchio L., Dagrada G. P., Konn Z. J., Tapper W. J., Walker B. A., Wardell C. P., Gregory W. M., Szubert A. J., Bell S. E., Child J. A., Jackson G. H., Davies F. E. and Morgan G. J. (20120330). A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial. : Leukemia.

MLA

Boyd K D, Ross F M, Chiecchio L, Dagrada G P, Konn Z J, Tapper W J, Walker B A, Wardell C P, Gregory W M, Szubert A J, Bell S E, Child J A, Jackson G H, Davies F E and Morgan G J. A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial. : Leukemia. 20120330.